Director, Head of Value, Evidence & Access
About this opportunity
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com .
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
Job Function:
Market Access
Job Sub Function:
Health Economics Market Access
Job Category:
People Leader
All Job Posting Locations:
Chiyoda, Tokyo, Japan
Job Description:
Director, Head of Value, Evidence & Access
Role and Responsibilities
The Director, Head of Value, Evidence & Access (VE&A) is a key strategic position in Integrated Market Access Team (IMAT) and Johnson & Johnson Innovative Medicine Japan (J&J IM Japan/Janssen Japan) to drive Japan HTA (Cost-Effective Analysis/CEA) preparation, submission and negotiation, as well as evidence generation to meet access needs. In the evolving healthcare environment in Japan, this position will work with other department heads in IMAT (e.g. Pricing, Policy) to design for access and strengthen the market access capability within the organization. The Head of VE&A will also work closely with other functions in J&J IM Japan including NPP (New Product Planning), MAF, R&D and Commercial, as well as regional and global leaders.
The main responsibilities are:
Lead the team to assess likelihood of Japan HTA designation during LRFP and other decision-making process.
Drive strategy of Japan HTA preparation, submission and negotiation.
Participate in IMAT Leadership reviews for key access decisions.
Build overall Market Access evidence generation strategy for J&J IM Japan, which should be aligned with local company’s and regional/global market access strategy.
Work closely with regional / global market access team to communicate Japan’s access evidence needs.
Work closely with cross functional teams to develop and strengthen company’s market access and evidence generation capability.
and maintain strategic relationships with key external stakeholders, e.g. Industry associations, Academia key opinion leaders; Support external engagement on HTA related policy strategy in collaboration with the policy department.
Manage budget and lead the team members as a people manager
Qualification Requirement
Experience
• Minimum 8 years of experience in health economics or market access in healthcare industry is required.
• In-depth understanding of Japanese governments and their perspective on Healthcare/Social insurance strategy is required.
• Knowledge on health economic analysis, cost-effective analysis (CEA), and methodology used in evidence generation.
• Experience in building teams and managing people and budgets.
• Experience in working successfully in complex matrix environments.
Education
• Higher degree in related fields such as Pharmacy, Health Economics, Outcomes Research, Health Services Research, Public Health, and Epidemiology is preferred.
Skills and Capabilities
• Strong collaboration/communication skills.
• Ability to drive and shape the decision-making.
• Clear prioritization.
• Ability to understand both science and business strategy; Identify solutions to support the company’s business goals.
• Adaptability to the local culture and way of working.
• Ability to build a high-performing team while accurately assessing the upward potential of subordinates and developing skills and leadership tailored to each individual.
• Business English skill is required; Japanese is preferred.
Required Skills:
Preferred Skills:
Agility Jumps, Commercial Awareness, Competitive Landscape Analysis, Developing Others, Global Market, Health Economics, Health Intelligence, Inclusive Leadership, Leadership, Market Knowledge, Market Opportunity Assessment, Operations Management, Performance Measurement, Pricing Strategies, Program Management, Regulatory Compliance, Strategic Change
Job details
How this role compares
Computed from every other active Market Access role in our database, not just this employer's listings.
We currently track 48 comparable Director Market Access roles across 18 biopharma companies.
Salary context
23 of 48 peers report a salary range (USD, annualized)
Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.
Where these roles are based
Top locations among the 48 comparable roles
Seniority mix
48 of 48 peers have a known seniority level
Therapeutic area mix
19 of 48 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden
Similar opportunities
The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.
Notify me about similar jobs
Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.
How we calculate "similar"
No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.
Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.
0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.